Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions.

Literature DB >> 17460705

Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions.

A Tefferi, T L Lasho, R A Mesa, A Pardanani, R P Ketterling, C A Hanson.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 17460705 DOI： 10.1038/sj.leu.2404711

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. New drugs for the treatment of myelofibrosis.

Authors: Ruben A Mesa
Journal: Curr Hematol Malig Rep Date: 2010-01 Impact factor: 3.952

2. Bortezomib therapy in myelofibrosis: a phase II clinical trial.

Authors: R A Mesa; S Verstovsek; C Rivera; A Pardanani; K Hussein; T Lasho; W Wu; A Tefferi
Journal: Leukemia Date: 2008-02-28 Impact factor: 11.528

Review 3. Management of Myelofibrosis-Related Cytopenias.

Authors: Prithviraj Bose; Srdan Verstovsek
Journal: Curr Hematol Malig Rep Date: 2018-06 Impact factor: 3.952

4. Initial testing of lenalidomide by the pediatric preclinical testing program.

Authors: C Patrick Reynolds; Min H Kang; Stephen T Keir; Richard Gorlick; E Anders Kolb; Richard Lock; John M Maris; Hernan Carol; Christopher L Morton; Catherine A Billups; Malcolm A Smith; Peter J Houghton
Journal: Pediatr Blood Cancer Date: 2011-02-25 Impact factor: 3.167

5. Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathology.

Authors: Ayalew Tefferi; Pierre Noel; Curtis A Hanson
Journal: J Mol Diagn Date: 2011-06-30 Impact factor: 5.568

6. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

Authors: Tiziano Barbui; Giovanni Barosi; Gunnar Birgegard; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Journal: J Clin Oncol Date: 2011-01-04 Impact factor: 44.544

Review 7. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.

Authors: Tiziano Barbui; Ayalew Tefferi; Alessandro M Vannucchi; Francesco Passamonti; Richard T Silver; Ronald Hoffman; Srdan Verstovsek; Ruben Mesa; Jean-Jacques Kiladjian; Rȕdiger Hehlmann; Andreas Reiter; Francisco Cervantes; Claire Harrison; Mary Frances Mc Mullin; Hans Carl Hasselbalch; Steffen Koschmieder; Monia Marchetti; Andrea Bacigalupo; Guido Finazzi; Nicolaus Kroeger; Martin Griesshammer; Gunnar Birgegard; Giovanni Barosi
Journal: Leukemia Date: 2018-02-27 Impact factor: 11.528